letter
-
Biologics
Bone Biologics CEO Issues Letter to Stockholders
BURLINGTON, Mass., October 25, 2022 (BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today…
Read More » -
Shareholder Letter from Founder, Executive Chairman & CEO CJ Wiggins regarding HippoFi®
September 7, 2022 – OrthoSpineNews- Dear Shareholders, I am writing to you, to share our team’s accomplishments over the last…
Read More » -
Hospitals
In letter to Franken, FDA defends handling of Medtronic’s Infuse study
By Jim Spencer and Joe Carlson Star Tribune The U.S. Food and Drug Administration is defending a decision to…
Read More » -
Biologics
BioRestorative Therapies Provides Company Updates With Shareholder Letter
MELVILLE, N.Y., Dec. 21, 2015 (GLOBE NEWSWIRE) — BioRestorative Therapies, Inc. (the “Company”) (OTCBB:BRTX), a life sciences company focused on…
Read More » -
Spine
NASS to Washington Post: Don’t Condemn All Spinal Fusions
The North American Spine Society Executive Committee has penned a letter to the Washington Post in response to a story…
Read More » -
Internal Fixation Systems, Inc. Today Sent the Following Letter to Its Shareholders
MIAMI, Jan. 4, 2012 — /PRNewswire/ — Internal Fixation Systems, Inc. (OTC QB: IFIX) Dear Shareholders:As we approach the end…
Read More » -
Spine
U.S. Senate panel probes Medtronic
A U.S. Senate committee has launched an investigation into reports that doctors with financial ties to the medical device company…
Read More » -
Spine
Official Senate Letter to Medtronic
http://media.jsonline.com/documents/Medtronic_Infuse_6_21_2011.pdf June 21, 2011Via Electronic TransmissionOmar Ishrak, Ph.D.Chairman and Chief Executive OfficerMedtronic, Inc.710 Medtronic ParkwayMinneapolis, MN 55432Dear Dr. Ishrak:The United…
Read More » -
Stryker Says One Of Four FDA Warning Letters Now Resolved
Stryker Corp. (SYK) has resolved one of four warning letters issued by the Food and Drug Administration in recent years…
Read More »